Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DR26FCN8X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,819
Award facts
- Contract value 100% obligated
- $14,818.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,818.68 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on November 12, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tezspire is a biologic medication used in the treatment of severe asthma and chronic rhinosinusitis with nasal polyposis, representing a specialty pharmaceutical product within the company's broader federal medical supply portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical prime vendor agreement enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen leverages this expansive contract vehicle to deliver specialty medications, brand-name and generic drugs, and related medical commodities to customers including the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCN8X?
SPE2DR26FCN8X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCN8X worth?
The government has obligated $14,819 on SPE2DR26FCN8X.
Is contract SPE2DR26FCN8X an order under another contract?
Yes. SPE2DR26FCN8X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCN8X competed?
The extent of competition for SPE2DR26FCN8X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award